TY - JOUR
T1 - Family history and polygenic risk of cardiovascular disease
T2 - Independent factors associated with secondary cardiovascular events in patients undergoing carotid endarterectomy
AU - Timmerman, Nathalie
AU - de Kleijn, Dominique P.V.
AU - de Borst, Gert J.
AU - den Ruijter, Hester M.
AU - Asselbergs, Folkert W.
AU - Pasterkamp, Gerard
AU - Haitjema, Saskia
AU - van der Laan, Sander W.
N1 - Funding Information:
Dr. Van der Laan was funded through grants from the Netherlands CardioVascular Research Initiative of the Netherlands Heart Foundation ( CVON 2011/B019 and CVON 2017–20 : Generating the best evidence-based pharmaceutical targets for atherosclerosis [GENIUS I&II]). Dr. Timmerman, Dr. De Borst, Dr. De Kleijn, and Dr. Pasterkamp are funded through the EU 755320 Taxinomisis grant. We acknowledge the European Research Area Network on Cardiovascular diseases (ERA-CVD, grant number 01KL1802). There are no competing interests declared.
Publisher Copyright:
© 2020 The Authors
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/8
Y1 - 2020/8
N2 - Background and aims: Family history (FHx) of cardiovascular disease (CVD) is a risk factor for CVD and a proxy for cardiovascular heritability. Polygenic risk scores (PRS) summarizing >1 million variants for coronary artery disease (CAD) are associated with incident and recurrent CAD events. However, little is known about the influence of FHx or PRS on secondary cardiovascular events (sCVE) in patients undergoing carotid endarterectomy (CEA). Methods: We included 1788 CEA patients from the Athero-Express Biobank. A weighted PRS for CAD including 1.7 million variants was calculated (MetaGRS). The composite endpoint of sCVE during three years of follow-up included coronary, cerebrovascular and peripheral events and cardiovascular death. We assessed the impact of FHx and MetaGRS on sCVE and carotid plaque composition. Results: Positive FHx was associated with a higher 3-year risk of sCVE independent of cardiovascular risk factors and MetaGRS (adjusted HR 1.40, 95%CI 1.07–1.82, p = 0.013). Patients in the highest MetaGRS quintile had a higher 3-year risk of sCVE compared to the rest of the cohort independent of cardiovascular risk factors including FHx (adjusted HR 1.35, 95%CI 1.01–1.79, p = 0.043), and their atherosclerotic plaques contained more fat (adjusted OR 1.59, 95%CI, 1.11–2.29, p = 0.013) and more macrophages (OR 1.49, 95%CI 1.12–1.99, p = 0.006). Conclusions: In CEA patients, both positive FHx and higher MetaGRS were independently associated with increased risk of sCVE. Moreover, higher MetaGRS was associated with vulnerable plaque characteristics. Future studies should unravel underlying mechanisms and focus on the added value of PRS and FHx in individual risk prediction for sCVE.
AB - Background and aims: Family history (FHx) of cardiovascular disease (CVD) is a risk factor for CVD and a proxy for cardiovascular heritability. Polygenic risk scores (PRS) summarizing >1 million variants for coronary artery disease (CAD) are associated with incident and recurrent CAD events. However, little is known about the influence of FHx or PRS on secondary cardiovascular events (sCVE) in patients undergoing carotid endarterectomy (CEA). Methods: We included 1788 CEA patients from the Athero-Express Biobank. A weighted PRS for CAD including 1.7 million variants was calculated (MetaGRS). The composite endpoint of sCVE during three years of follow-up included coronary, cerebrovascular and peripheral events and cardiovascular death. We assessed the impact of FHx and MetaGRS on sCVE and carotid plaque composition. Results: Positive FHx was associated with a higher 3-year risk of sCVE independent of cardiovascular risk factors and MetaGRS (adjusted HR 1.40, 95%CI 1.07–1.82, p = 0.013). Patients in the highest MetaGRS quintile had a higher 3-year risk of sCVE compared to the rest of the cohort independent of cardiovascular risk factors including FHx (adjusted HR 1.35, 95%CI 1.01–1.79, p = 0.043), and their atherosclerotic plaques contained more fat (adjusted OR 1.59, 95%CI, 1.11–2.29, p = 0.013) and more macrophages (OR 1.49, 95%CI 1.12–1.99, p = 0.006). Conclusions: In CEA patients, both positive FHx and higher MetaGRS were independently associated with increased risk of sCVE. Moreover, higher MetaGRS was associated with vulnerable plaque characteristics. Future studies should unravel underlying mechanisms and focus on the added value of PRS and FHx in individual risk prediction for sCVE.
KW - Atherosclerosis
KW - Carotid artery stenosis
KW - Carotid endarterectomy
KW - Family history
KW - Polygenic risk score
KW - Vascular biology
UR - http://www.scopus.com/inward/record.url?scp=85087377508&partnerID=8YFLogxK
U2 - 10.1016/j.atherosclerosis.2020.04.013
DO - 10.1016/j.atherosclerosis.2020.04.013
M3 - Article
C2 - 32624175
SN - 0021-9150
VL - 307
SP - 121
EP - 129
JO - Atherosclerosis
JF - Atherosclerosis
ER -